Title : Long-term follow-up of inflammatory bowel disease patients receiving anti-tumor necrosis factor-alpha therapy

Pub. Date : 2020 Nov 22

PMID : 33226355






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 SUMMARY: INTRODUCTION: Anti-tumor necrosis factor-alpha (anti-TNFalpha) treatment is reserved for steroid-dependent or steroid/immunomodulator-refractory inflammatory bowel diseases patients. Steroids tumor necrosis factor Homo sapiens
2 SUMMARY: INTRODUCTION: Anti-tumor necrosis factor-alpha (anti-TNFalpha) treatment is reserved for steroid-dependent or steroid/immunomodulator-refractory inflammatory bowel diseases patients. Steroids tumor necrosis factor Homo sapiens
3 SUMMARY: INTRODUCTION: Anti-tumor necrosis factor-alpha (anti-TNFalpha) treatment is reserved for steroid-dependent or steroid/immunomodulator-refractory inflammatory bowel diseases patients. Steroids tumor necrosis factor Homo sapiens
4 SUMMARY: INTRODUCTION: Anti-tumor necrosis factor-alpha (anti-TNFalpha) treatment is reserved for steroid-dependent or steroid/immunomodulator-refractory inflammatory bowel diseases patients. Steroids tumor necrosis factor Homo sapiens